Synexus' Pretoria Clinical Research Site Delivers World Beating Performance for Janssen Pharmaceutical K.K.
10/24/2011 11:39:05 AM
More...
|
Janssen Pharmaceutica Products, L.P. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
10/8/2007 7:07:47 AM
More...
|
Janssen Pharmaceutica Products, L.P. Selects INVEGA(TM) (paliperidone) Extended Release Tablets As Brand Name For Its Investigational Atypical Antipsychotic
11/10/2006 12:45:06 PM
More...
|
Janssen Pharmaceutica Products, L.P. Release: U.S. District Court Upholds RISPERDAL(R) Patent
10/16/2006 11:23:13 AM
More...
|
Janssen Pharmaceutica Products, L.P. Release: New Dosages Of RISPERDAL(R) (Risperidone) Now Available
3/24/2006 12:41:52 PM
More...
|
Janssen Pharmaceutica Products, L.P., The Plaintiffs Steering Committee And The State Liaison Committee Of The PROPULSID Multi-District Litigation Announce Agreement To Resolve Remaining Federal And State Court Cases
12/16/2005 10:28:43 AM
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) To Discuss Full Approval Of VELCADE(R) (bortezomib) For Injection In Second-Line Multiple Myeloma
10/19/2005 5:13:09 PM
More...
|
Janssen Pharmaceutica Products, L.P. Award-Winning Documentary On Schizophrenia To Be Screened At Mental Health Meeting In San Francisco
10/19/2005 5:12:59 PM
More...
|
Kyowa Hakko Kogyo Co., Ltd. , Janssen Pharmaceutica Products, L.P. To End Distribution Partnership For Itrizole Capsule
10/19/2005 5:12:49 PM
More...
|
Nippon Shinyaku Co., Ltd., Janssen Pharmaceutica Products, L.P. , Grunenthal GmbH To Collaborate In Development Of Oral Analgesic In Japan
10/19/2005 5:12:47 PM
More...
|
|